The prevalence and prevention of nasopharyngeal carcinoma in China.
about
The criteria to confirm the role of Epstein-Barr virus in nasopharyngeal carcinoma initiationRole of chemotherapy in nasopharyngeal carcinomaEpstein-Barr Virus: Diseases Linked to Infection and TransformationGenetic variations in radiation and chemotherapy drug action pathways and survival in locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapyReactive oxygen species mediate Epstein-Barr virus reactivation by N-methyl-N'-nitro-N-nitrosoguanidineNeurosurgical interventions for patients with nasopharyngeal carcinoma: a single institution experiencePhase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinomaSafety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.Multi-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens.Nasopharyngeal carcinoma as a paradigm of cancer geneticsTreatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapyInhibition of autophagy results in a reversal of taxol resistance in nasopharyngeal carcinoma by enhancing taxol-induced caspase-dependent apoptosisBMP2 promotes proliferation and invasion of nasopharyngeal carcinoma cells via mTORC1 pathwayEpstein-Barr virus (EBV) infection in Chinese children: a retrospective study of age-specific prevalence.Identification of CD24 as a cancer stem cell marker in human nasopharyngeal carcinoma.Functional PIN1 promoter polymorphisms associated with risk of nasopharyngeal carcinoma in Southern Chinese populationsOutcome and long-term efficacy of four facio-cervical fields conformal radiotherapy for nasopharyngeal carcinomamiR-21 inhibitor suppresses proliferation and migration of nasopharyngeal carcinoma cells through down-regulation of BCL2 expression.Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis.A new T classification based on masticator space involvement in nasopharyngeal carcinoma: a study of 742 cases with magnetic resonance imagingTumor microenvironment macrophage inhibitory factor directs the accumulation of interleukin-17-producing tumor-infiltrating lymphocytes and predicts favorable survival in nasopharyngeal carcinoma patients.Lowered risk of nasopharyngeal carcinoma and intake of plant vitamin, fresh fish, green tea and coffee: a case-control study in Taiwan.Expansion of cancer registration in China.Nicotine promotes proliferation of human nasopharyngeal carcinoma cells by regulating α7AChR, ERK, HIF-1α and VEGF/PEDF signaling.Familial nasopharyngeal carcinomas possess distinguished clinical characteristics in southern China.Prognoses and long-term outcomes of nasopharyngeal carcinoma in Han and Uyghur patients treated with intensity-modulated radiotherapy in the Xinjiang Autonomous Region of ChinaProteomic analysis on N, N'-dinitrosopiperazine-mediated metastasis of nasopharyngeal carcinoma 6-10B cells.High expression of ubiquitin-conjugating enzyme 2C (UBE2C) correlates with nasopharyngeal carcinoma progression.Nasopharyngeal Epstein-Barr Virus Load: An Efficient Supplementary Method for Population-Based Nasopharyngeal Carcinoma Screening.Fluctuations of epstein-barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up.Human-derived IgG level as an indicator for EBV-associated lymphoma model in Hu-PBL/SCID chimeras.The impact of baseline serum C-reactive protein and C-reactive protein kinetics on the prognosis of metastatic nasopharyngeal carcinoma patients treated with palliative chemotherapyEpstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.SOX1 down-regulates β-catenin and reverses malignant phenotype in nasopharyngeal carcinoma.N,N'-dinitrosopiperazine-mediated AGR2 is involved in metastasis of nasopharyngeal carcinomaPhase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma.The significant survival advantage of female sex in nasopharyngeal carcinoma: a propensity-matched analysis.Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes.Heterogeneity revealed through meta-analysis might link geographical differences with nasopharyngeal carcinoma incidence in Han Chinese populations.WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis.
P2860
Q26853527-63E918A8-9B9E-4919-BF7E-01C16DD679E3Q27022454-5EF99D8E-071D-483E-A2E7-8C009E1CA69CQ28074586-12334E85-8892-4A10-B304-01789D4C7D91Q28536735-ED3203F7-23BA-43AC-B4FB-E1691F8B56FAQ28537881-8D197583-4FC8-4E84-BD59-6E96096D0571Q30446317-986C4360-B2E8-4B91-9563-338BB55AF9B9Q33428455-61AF02EB-7B3E-4F0F-966F-C0673BD61DB4Q33439337-B14F4B54-C158-40D5-833B-CACC58D0D34FQ33439361-D3B89F1C-9371-4C9B-A3D1-F4B0D0BBBA76Q33579427-DD9DD6D4-07B0-46AE-A6B8-B62E91616830Q33579689-57AB3761-AA5E-458E-BAE0-EF29071CAD33Q33623195-C2B376BF-7F92-4B8E-BA45-FDF647647D7FQ33657520-A4D44E11-BC47-4A08-8EA5-0B26D32CBDFFQ33734608-4695D8D1-19F4-4A89-91FB-4C53F933CAD6Q33793359-F976F84E-983F-459B-B1AF-B2B4DC763052Q33870813-EE5F871D-2B9F-4333-AA8C-760E8FF205D4Q33889375-E03923A7-3B44-4F40-B16A-92BA5639DB80Q33898669-437E80F6-5678-4548-A7B9-6D9701DE03E9Q33953134-8D665155-ACF5-4DF2-808C-F638518909EDQ34174371-4E4A378A-D03A-4805-BFB1-5ABD52F56CFDQ34294055-EED3FFB1-AE9A-479B-B5FE-5165F2A0D52DQ34359007-4B628964-2D89-4D08-91DD-BECBE73FDC50Q34367489-9A908578-DC27-4859-8B62-09DDD4268D59Q34405806-B4609289-B422-4AEC-B3D5-273D18A3851FQ34452737-06C6EC8F-0C6E-4072-8A58-AAFE28D35400Q34465715-B9093FD7-8951-4AE5-A801-B181EED5FBB5Q34479612-305AC14D-BB6E-4297-87BB-CE0DF891989CQ34669229-56D59052-AB4E-4A1C-AA02-0999794DD997Q34671337-C926C986-1A44-46D2-9AB0-EB8077F7A79FQ34841962-56EEE089-FEC9-4B09-9B26-0C210A8D54CEQ35003923-DD020CA9-22FC-4DD7-88A9-9F92FA364E6AQ35018650-B5C8510B-E2D8-4A80-8307-094BA152F335Q35032548-708FD091-6A47-4912-8E40-2510B99FFFEFQ35079337-06F2B85B-1531-4414-A473-CE356506B801Q35143700-7B5F065D-732A-4E92-9124-AB3E57D015D0Q35507358-6F3810D8-D215-4552-AEDC-A6F4DC0477CDQ35677945-438A3021-B330-4805-96E9-D64A33F328E2Q35754655-DB0F0E2F-48B2-4D7A-B329-6710E27B0B67Q35755326-E792B619-581D-4ED1-923F-DCC367B32B35Q35832964-558059D7-28B1-4238-96E0-72C78D876E44
P2860
The prevalence and prevention of nasopharyngeal carcinoma in China.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The prevalence and prevention of nasopharyngeal carcinoma in China.
@ast
The prevalence and prevention of nasopharyngeal carcinoma in China.
@en
The prevalence and prevention of nasopharyngeal carcinoma in China.
@nl
type
label
The prevalence and prevention of nasopharyngeal carcinoma in China.
@ast
The prevalence and prevention of nasopharyngeal carcinoma in China.
@en
The prevalence and prevention of nasopharyngeal carcinoma in China.
@nl
prefLabel
The prevalence and prevention of nasopharyngeal carcinoma in China.
@ast
The prevalence and prevention of nasopharyngeal carcinoma in China.
@en
The prevalence and prevention of nasopharyngeal carcinoma in China.
@nl
P2093
P2860
P356
P1476
The prevalence and prevention of nasopharyngeal carcinoma in China
@en
P2093
Chao-Nan Qian
Malcolm J Simons
Su-Mei Cao
P2860
P304
P356
10.5732/CJC.010.10377
P5008
P577
2011-02-01T00:00:00Z